Citation

Takeuchi CS, Kim BG, Blazey CM, Ma S, Johnson HW, Anand NK, Arcalas A, Baik TG, Buhr CA, Cannoy J, Epshteyn S, Joshi A, Lara K, Lee MS, Wang L, Leahy JW, Nuss JM, Aay N, Aoyama R, Foster P, Lee J, Lehoux I, Munagala N, Plonowski A, Rajan S, Woolfrey J, Yamaguchi K, Lamb P, Miller N.: Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR). J Med Chem, Volume 56 (6), 2013

Authors

Aay N, Anand NK, Aoyama R, Arcalas A, Baik TG, Blazey CM, Buhr CA, Cannoy J, Epshteyn S, Foster P, Johnson HW, Joshi A, Kim BG, Lamb P, Lara K, Leahy JW, Lee J, Lee MS, Lehoux I, Ma S, Miller N., Munagala N, Nuss JM, Plonowski A, Rajan S, Takeuchi CS, Wang L, Woolfrey J, Yamaguchi K

Journal

J Med Chem

Year

2013

DOI

10.1021/jm3007933

PubMed

23394126

Machine-readable

REST APIRDF